To include your compound in the COVID-19 Resource Center, submit it here.

HGS-ETR2: Phase I data

In an ongoing, open-label, dose-escalation, U.K. Phase I trial in

Read the full 103 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE